The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial-Reference-Cited by-同舟云学术

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

Published:2021-02 Issue: Volume:32 Page:100720
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Chaccour Carlos^ORCID,Casellas Aina,Blanco-Di Matteo Andrés^ORCID,Pineda Iñigo,Fernandez-Montero Alejandro,Ruiz-Castillo Paula,Richardson Mary-Ann,Rodríguez-Mateos Mariano,Jordán-Iborra Carlota,Brew Joe,Carmona-Torre Francisco,Giráldez Miriam,Laso Ester,Gabaldón-Figueira Juan C.,Dobaño Carlota,Moncunill Gemma,Yuste José R.,Del Pozo Jose L.,Rabinovich N.Regina,Schöning Verena,Hammann Felix,Reina Gabriel,Sadaba Belen,Fernández-Alonso Mirian

Funder

Barcelona Institute of Science and Technology

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. WHO. COVID-19 Weekly epidemiological update - 15 December 2020. Available at https://www.who.int/publications/m/item/weekly-epidemiological-update—15-december-2020 (Accessed December 21, 2020).

2. Difficult to determine herd immunity threshold for COVID-19;Rubin;JAMA,2020

3. COVID-19 herd immunity: where are we?;Fontanet;Nat Rev Immunol,2020

4. WHO. Newsroom - coronavirus disease (COVID-19): vaccines. Available at https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines (accessed December 21, 2020).

5. Ivermectin is a specific inhibitor of importin alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus;Wagstaff;Biochem J,2012

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ivermectin for treatment of non-hospitalized COVID-19 patients: A systematic review and meta-analysis of 12 randomized controlled trials with 7,035 participants;International Journal of Antimicrobial Agents;2024-08

2. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial;BMC Infectious Diseases;2024-07-22

3. Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial;Jundishapur Journal of Health Sciences;2024-04-30

4. Ivermectin for treatment of COVID-19: A systematic review and meta-analysis;Heliyon;2024-03

5. Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin;Scientific Reports;2024-02-02